bioAffinity Technologies financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

바이오어피니티 테크놀로지스NASDAQ:BIAF · Nasdaq · Healthcare

$6.05-1.46%

2026-10-02 close

bioAffinity Technologies's published financial data is dated 2026-10-04. 2024 revenue was $9M. 2024 operating profit was −$9M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy